rs3738136

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032409.3(PINK1):​c.1018G>A​(p.Ala340Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0641 in 1,613,752 control chromosomes in the GnomAD database, including 5,875 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 462 hom., cov: 31)
Exomes 𝑓: 0.065 ( 5413 hom. )

Consequence

PINK1
NM_032409.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.03

Publications

46 publications found
Variant links:
Genes affected
PINK1 (HGNC:14581): (PTEN induced kinase 1) This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008]
PINK1-AS (HGNC:38872): (PINK1 antisense RNA)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0056702495).
BP6
Variant 1-20645618-G-A is Benign according to our data. Variant chr1-20645618-G-A is described in ClinVar as Benign. ClinVar VariationId is 295004.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.248 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PINK1NM_032409.3 linkc.1018G>A p.Ala340Thr missense_variant Exon 5 of 8 ENST00000321556.5 NP_115785.1 Q9BXM7-1
PINK1-ASNR_046507.1 linkn.3948C>T non_coding_transcript_exon_variant Exon 2 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PINK1ENST00000321556.5 linkc.1018G>A p.Ala340Thr missense_variant Exon 5 of 8 1 NM_032409.3 ENSP00000364204.3 Q9BXM7-1
PINK1ENST00000400490.2 linkn.111G>A non_coding_transcript_exon_variant Exon 1 of 4 2
PINK1-ASENST00000451424.1 linkn.3948C>T non_coding_transcript_exon_variant Exon 2 of 3 2
PINK1ENST00000492302.1 linkn.2106G>A non_coding_transcript_exon_variant Exon 3 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.0548
AC:
8320
AN:
151828
Hom.:
461
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0163
Gnomad AMI
AF:
0.0373
Gnomad AMR
AF:
0.0627
Gnomad ASJ
AF:
0.0424
Gnomad EAS
AF:
0.261
Gnomad SAS
AF:
0.230
Gnomad FIN
AF:
0.0869
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0448
Gnomad OTH
AF:
0.0479
GnomAD2 exomes
AF:
0.0921
AC:
23161
AN:
251368
AF XY:
0.0971
show subpopulations
Gnomad AFR exome
AF:
0.0169
Gnomad AMR exome
AF:
0.100
Gnomad ASJ exome
AF:
0.0362
Gnomad EAS exome
AF:
0.265
Gnomad FIN exome
AF:
0.0930
Gnomad NFE exome
AF:
0.0451
Gnomad OTH exome
AF:
0.0701
GnomAD4 exome
AF:
0.0651
AC:
95106
AN:
1461814
Hom.:
5413
Cov.:
38
AF XY:
0.0696
AC XY:
50621
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.0130
AC:
434
AN:
33480
American (AMR)
AF:
0.0947
AC:
4236
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0413
AC:
1079
AN:
26136
East Asian (EAS)
AF:
0.258
AC:
10228
AN:
39694
South Asian (SAS)
AF:
0.215
AC:
18563
AN:
86258
European-Finnish (FIN)
AF:
0.0929
AC:
4962
AN:
53398
Middle Eastern (MID)
AF:
0.0371
AC:
214
AN:
5766
European-Non Finnish (NFE)
AF:
0.0460
AC:
51105
AN:
1111972
Other (OTH)
AF:
0.0710
AC:
4285
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
5589
11178
16767
22356
27945
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2218
4436
6654
8872
11090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0547
AC:
8316
AN:
151938
Hom.:
462
Cov.:
31
AF XY:
0.0600
AC XY:
4459
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.0163
AC:
678
AN:
41472
American (AMR)
AF:
0.0629
AC:
959
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.0424
AC:
147
AN:
3468
East Asian (EAS)
AF:
0.260
AC:
1333
AN:
5126
South Asian (SAS)
AF:
0.229
AC:
1097
AN:
4800
European-Finnish (FIN)
AF:
0.0869
AC:
916
AN:
10538
Middle Eastern (MID)
AF:
0.0171
AC:
5
AN:
292
European-Non Finnish (NFE)
AF:
0.0448
AC:
3047
AN:
67974
Other (OTH)
AF:
0.0474
AC:
100
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
365
730
1095
1460
1825
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0491
Hom.:
1330
Bravo
AF:
0.0496
TwinsUK
AF:
0.0440
AC:
163
ALSPAC
AF:
0.0446
AC:
172
ESP6500AA
AF:
0.0182
AC:
80
ESP6500EA
AF:
0.0473
AC:
407
ExAC
AF:
0.0921
AC:
11176
Asia WGS
AF:
0.203
AC:
703
AN:
3478
EpiCase
AF:
0.0425
EpiControl
AF:
0.0451

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 26% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 24. Only high quality variants are reported. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Autosomal recessive early-onset Parkinson disease 6 Benign:3
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23459931, 17084972, 31182772) -

PINK1-related disorder Benign:1
Mar 20, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
9.7
DANN
Benign
0.76
DEOGEN2
Benign
0.069
T
Eigen
Benign
-0.99
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.29
T
MetaRNN
Benign
0.0057
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.42
N
PhyloP100
1.0
PrimateAI
Benign
0.36
T
PROVEAN
Benign
1.3
N
REVEL
Benign
0.12
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0020
B
Vest4
0.054
MPC
0.17
ClinPred
0.0016
T
GERP RS
2.4
Varity_R
0.015
gMVP
0.34
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3738136; hg19: chr1-20972111; COSMIC: COSV58631402; API